© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 11, 892-897,
June 2, 1993
© 1993 Oxford University Press
The Lifetime Risk of Developing Breast Cancer
Division of Cancer Prevention and Control, National Cancer Institute Bethesda, Md
American Cancer Society Atlanta, Ga
Division of Epidemiology, Emory University Atlanta, Ga
IMS, Inc. Silver Spring Md
Correspondence to: Eric J. Feuer, Ph.D., National Cancer Institute, EPN-313, 9000 Rockville Pike, Bethesda, MD 20892.
Background: The lifetime risk of developing breast cancer in U.S. women, often quoted as one in nine, is a commonly cited cancer statistic. However, many estimates have used cancer rates derived from total rather than the cancer-free population and have not properly accounted for multiple cancers in the same individual. Purpose: Our purpose was to provide a revised method for calculating estimates of the lifetime risk of developing breast cancer and to aid in interpretation of the estimates. Methods: A multiple decrement life table was derived by applying age-specific incidence and mortality rates from cross-sectional data to a hypothetical cohort of women. Incidence, mortality, and population data from 1975–1988 were used, representing the geographic areas of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. The incidence rates reflected only the first breast primary cancer; mortality rates reflected causes other than breast cancer. The population denominator used in calculating incidence rates was adjusted to reflect only those women without previously diagnosed breast cancers in the hypothetical cohort. Results: Our calculations showed an overall lifetime risk for developing invasive breast cancer of approximately one in eight with use of 1987–1988 SEER data, although up to age 85, it was still the commonly quoted one in nine. Conclusion: Our estimate was calculated assuming constant age-specific rates derived from 1987–1988 SEER data. Because incidence and mortality rates change over time, conditional risk estimates over the short term (10 or 20 years) may be more reliable. A large portion of the rise in the lifetime risk of breast cancer estimated using 1975–1977 data (one in 10.6) to an estimate using 1987–1988 data (one in eight) may be attributed to 1) early detection of prevalent cases due to increased use of mammographic screening and 2) lower mortality due to causes other than breast cancer. A common misperception is that the lifetime risk estimate assumes that all women live to a particular age (e.g., 85 or 95). In fact, the calculation assumes that women can die from causes other than breast cancer at any possible age. Cutting off the lifetime risk calculation at age 85 assumes that no women develop breast cancer after that age. While the lifetime risk of developing breast cancer rose over the period 1976–1977 to 1987–1988, the lifetime risk of dying of breast cancer increased from one in 30 to one in 28, reflecting generally flat mortality trends. [J Natl Cancer Inst 85:892–897, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. C. Allain Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology J. Mol. Diagn., September 1, 2008; 10(5): 383 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Martin, R. Reiter, M. Johnson, M. S. Shah, M. C. Iann, B. Singh, J. K. Richards, A. Wang, and A. Stoica Effects of Tobacco Smoke Condensate on Estrogen Receptor-{alpha} Gene Expression and Activity Endocrinology, October 1, 2007; 148(10): 4676 - 4686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yildirim-Assaf, A. Coumbos, W. Hopfenmuller, H.-D. Foss, H. Stein, and W. Kuhn The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer J. Clin. Pathol., June 1, 2007; 60(6): 649 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bernig, B. J. Boersma, T. M. Howe, R. Welch, S. Yadavalli, B. Staats, L. E. Mechanic, S. J. Chanock, and S. Ambs The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women Carcinogenesis, April 1, 2007; 28(4): 828 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Wood, A. L. Usborne, M. F. Starost, R. P. Tarara, L. R. Hill, L. M. Wilkinson, K. R. Geisinger, E. A. Feiste, and J. M. Cline Hyperplastic and neoplastic lesions of the mammary gland in macaques. Vet. Pathol., July 1, 2006; 43(4): 471 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, E. P. Leip, M. G. Larson, R. B. D'Agostino, A. Beiser, P. W.F. Wilson, P. A. Wolf, and D. Levy Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age Circulation, February 14, 2006; 113(6): 791 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fiegl, S. Millinger, G. Goebel, E. Muller-Holzner, C. Marth, P. W. Laird, and M. Widschwendter Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer Cancer Res., January 1, 2006; 66(1): 29 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Bowen, K. M. Battuello, and M. Raats Marketing Genetic Tests: Empowerment or Snake Oil? Health Educ Behav, October 1, 2005; 32(5): 676 - 685. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, T. J. Wang, E. P. Leip, M. G. Larson, D. Levy, R. S. Vasan, R. B. D'Agostino, J. M. Massaro, A. Beiser, P. A. Wolf, et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study Circulation, August 31, 2004; 110(9): 1042 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Widschwendter, K. D. Siegmund, H. M. Muller, H. Fiegl, C. Marth, E. Muller-Holzner, P. A. Jones, and P. W. Laird Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen Cancer Res., June 1, 2004; 64(11): 3807 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Riddle Diabetes: Too Big and Too Bad to Ignore Any Longer Clin. Diabetes, April 1, 2004; 22(2): 90 - 91. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Brinker and D. P. O'Connor The Incidence of Fractures and Dislocations Referred for Orthopaedic Services in a Capitated Population J. Bone Joint Surg. Am., February 1, 2004; 86(2): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Thull and V. G. Vogel Recognition and Management of Hereditary Breast Cancer Syndromes Oncologist, February 1, 2004; 9(1): 13 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stevens Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation Journal of Health Politics Policy and Law, December 1, 2003; 28(6): 1033 - 1088. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Steingart, M. Cotterchio, N. Kreiger, and M. Sloan Antidepressant medication use and breast cancer risk: a case-control study Int. J. Epidemiol., December 1, 2003; 32(6): 961 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Gloeckler Ries, M. E. Reichman, D. R. Lewis, B. F. Hankey, and B. K. Edwards Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program Oncologist, December 1, 2003; 8(6): 541 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. V. Narayan, J. P. Boyle, T. J. Thompson, S. W. Sorensen, and D. F. Williamson Lifetime Risk for Diabetes Mellitus in the United States JAMA, October 8, 2003; 290(14): 1884 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Brem, J. Baum, M. Lechner, S. Kaplan, S. Souders, L. G. Naul, and J. Hoffmeister Improvement in Sensitivity of Screening Mammography with Computer-Aided Detection: A Multiinstitutional Trial Am. J. Roentgenol., September 1, 2003; 181(3): 687 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Pinsky, B. S. Kramer, D. Reding, and S. Buys Reported Family History of Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Am. J. Epidemiol., May 1, 2003; 157(9): 792 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, M. G. Larson, E. P. Leip, A. Beiser, R. B. D'Agostino, W. B. Kannel, J. M. Murabito, R. S. Vasan, E. J. Benjamin, and D. Levy Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study Circulation, December 10, 2002; 106(24): 3068 - 3072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Markey, J. Y. Lo, and C. E. Floyd Jr Differences between Computer-aided Diagnosis of Breast Masses and That of Calcifications Radiology, March 21, 2002; (2002) 2232011257. [Abstract] [Full Text]
|
|
|
|
|
|
A. Muller, T. B. Edmonston, D. A. Corao, D. G. Rose, J. P. Palazzo, H. Becker, R. D. Fry, J. Rueschoff, and R. Fishel Exclusion of Breast Cancer as an Integral Tumor of Hereditary Nonpolyposis Colorectal Cancer Cancer Res., February 1, 2002; 62(4): 1014 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Allred, Y. H. Ju, K. F. Allred, J. Chang, and W. G. Helferich Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein Carcinogenesis, October 1, 2001; 22(10): 1667 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Smedira Practical Issues in Counseling Healthy Women About Their Breast Cancer Risk and Use of Tamoxifen Citrate Arch Intern Med, November 13, 2000; 160(20): 3034 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. SADLER, B. M. BOOTH, D. NIELSON, and B. N. DOEBBELING Health-Related Consequences of Physical and Sexual Violence: Women in the Military Obstet. Gynecol., September 1, 2000; 96(3): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Weisz, G. Fritz-Wolz, S. Gestl, G. A. Clawson, C. R. Creveling, J. G. Liehr, and D. Dabbs Nuclear Localization of Catechol-O-Methyltransferase in Neoplastic and Nonneoplastic Mammary Epithelial Cells Am. J. Pathol., June 1, 2000; 156(6): 1841 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Armstrong, A. Eisen, and B. Weber Assessing the Risk of Breast Cancer N. Engl. J. Med., February 24, 2000; 342(8): 564 - 571. [Full Text] [PDF]
|
|
|
|
|
|
M. B. Barton, R. Harris, and S. W. Fletcher Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How? JAMA, October 6, 1999; 282(13): 1270 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-X. An, A. Claas, L. Savelyeva, S. Seitz, P. Schlag, S. Scherneck, and M. Schwab Two Regions of Deletion in 9p23-24 in Sporadic Breast Cancer Cancer Res., August 1, 1999; 59(16): 3941 - 3943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Struewing, P. Hartge, S. Wacholder, S. M. Baker, M. Berlin, M. McAdams, M. M. Timmerman, L. C. Brody, and M. A. Tucker The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews N. Engl. J. Med., May 15, 1997; 336(20): 1401 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Jackman and R. L. Lamm Stereotactic Histologic Biopsy in Breasts with Implants Radiology, January 1, 2002; 222(1): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Markey, J. Y. Lo, and C. E. Floyd Jr Differences between Computer-aided Diagnosis of Breast Masses and That of Calcifications Radiology, May 1, 2002; 223(2): 489 - 493. [Abstract] [Full Text] [PDF]
|
|